A Step Toward Workplace Obesity Prevention: Evaluation of Weight Management Program for Hospital-based Health Care Providers

Background: Obesity is a worldwide problem. Healthy workplace and lifestyle are crucial in preventing obesity. A workplace weight management program could create a culture of health and facilitate weight control among health care providers. The present study aims to describe and evaluate the health outcomes of the interaction of professional practice and organizational infrastructure. Method: The hospital-based weight management program was an eight-week pilot randomized controlled study for obese health care providers. The primary outcomes were body weight and body mass index. The secondary outcomes included serum fasting glucose, fasting cholesterol, triglyceride, high- and low-density lipoprotein, body fat percentage, body mass, and quality of life. The RE-AIM framework was used to examine the intervention’s reach, effectiveness, adoption, implementation and maintenance at individual and organizational levels. Results: The program successfully attained the target population. Health care providers demonstrated short-term weight loss and decreased serum fasting cholesterol level after completing the program. The excellent retention rate (95%) of the study suggested that the participants were well-engaged in self-weight management. The program was implemented with adequate resource and support from the health organization. The organization may consider continuing the program in view of its long-term benefits to health care providers. Conclusion: Supportive organizational structure and culture enhanced professional practice and improved the health outcomes of the hospital-based weight management program participants

The impact of 3D Printing Technology on the Supply Chain: Manufacturing and Legal Perspectives

This is the final version. Available on open access from Elsevier via the DOI in this recordAn earlier version of this paper entitled “Impact of 3D Printing Technology on Supply Chain in China” was presented at the 24th International Conference on Production Research (ICPR 2017), Poznan, Poland, 30 July–3 August 2017. It is available in ORE at: http://hdl.handle.net/10871/311773D Printing (3DP) technology has been receiving increased public attention. Many companies are seeking ways to develop new means of creating and disseminating 3DP content, in order to capture new business opportunities. However, to date the true business opportunities of 3DP have not been completely uncovered. This research explores the challenges posed in the development and deployment of 3DP and focuses on China, which is still the main manufacturing hub of the world. The main purpose of this research is to uncover the obstacles that resist mass-scale applications of 3DP. By means of empirical semi-structured interviews with 3DP companies in China, it is found that many companies can see the benefits of 3DP, but its potential has not been delivered as promised. One reason is due to the fact that 3DP has not been integrated well in the supply chain. The other reason concerns potential intellectual property issues that cannot effectively prevent counterfeiting. To tackle the above issues, several areas have been identified that could be improved further. In particular, the legal complications concerning 3D-printed content could be overcome by a licensing platform.The work is sponsored by the Arts and Humanities Research Council, and the Newton Fund, for the project “A Technological Licensing Framework for 3D printed content: A Focus on China”

Defect-free outer-selective hollow fiber thin-film composite membranes for forward osmosis applications

© 2019 Elsevier B.V. This study presents the successful fabrication of a novel defect-free outer-selective hollow fiber (OSHF) thin-film composite (TFC) membrane for forward osmosis (FO) applications. Thin and porous FO membrane substrates made of polyether sulfone (PES) with a dense and smooth outer surface were initially fabricated at different air-gap distances. A modified vacuum-assisted interfacial polymerization (VAIP) technique was then successfully utilised for coating polyamide (PA) layer on the hollow fiber (HF) membrane substrate to prepare OSHF TFC membranes. Experimental results showed that the molecular weight cut-off (MWCO) of the surface of the membrane substrate should be less than 88 kDa with smooth surface roughness to obtain a defect-free PA layer via VAIP. The FO test results showed that the newly developed OSHF TFC membranes achieved water flux of 30.2 L m−2 h−1 and a specific reverse solute flux of 0.13 g L−1 using 1 M NaCl and DI water as draw and feed solution, respectively. This is a significant improvement on commercial FO membranes. Moreover, this OSHF TFC FO membrane demonstrated higher fouling resistance and better cleaning efficiency against alginate-silica fouling. This membrane also has a strong potential for scale-up for use in larger applications. It also has strong promise for various FO applications such as osmotic membrane bioreactor (OMBR) and fertilizer-drawn OMBR processes

Physiological Functions of the COPI Complex in Higher Plants

COPI vesicles are essential to the retrograde transport of proteins in the early secretory pathway. The COPI coatomer complex consists of seven subunits, termed alpha-, beta-, beta'-, gamma-, delta-, epsilon-, and zeta-COP, in yeast and mammals. Plant genomes have homologs of these subunits, but the essentiality of their cellular functions has hampered the functional characterization of the subunit genes in plants. Here we have employed virus-induced gene silencing (VIGS) and dexamethasone (DEX)-inducible RNAI of the COPI subunit genes to study the in vivo functions of the COPI coatomer complex in plants. The beta'-, gamma-, and delta-COP subunits localized to the Golgi as GFP-fusion proteins and interacted with each other in the Golgi. Silencing of beta'-, gamma-, and delta-COP by VIGS resulted in growth arrest and acute plant death in Nicotiana benthamiana, with the affected leaf cells exhibiting morphological markers of programmed cell death. Depletion of the COPI subunits resulted in disruption of the Golgi structure and accumulation of autolysosome-like structures in earlier stages of gene silencing. In tobacco BY-2 cells, DEX-inducible RNAi of beta'-COP caused aberrant cell plate formation during cytokinesis. Collectively, these results suggest that COPI vesicles are essential to plant growth and survival by maintaining the Golgi apparatus and modulating cell plate formation.1196Ysciescopu

GreenPRO: A novel fertiliser-driven osmotic power generation process for fertigation

© 2018 This study introduces and describes GreenPRO, a novel concept involving fertiliser-driven osmotic energy generation via pressure retarded osmosis (PRO). The potential of GreenPRO was proposed for three objectives: (a) power generation, (b) water pressurisation for fertiliser-based irrigation, and (c) water treatment, as a holistic water-energy-food nexus process. Three pure agricultural fertilisers and two commercial blended fertiliser solutions were used as the draw solution and irrigation water as feed to test this concept for power generation. Theoretical thermodynamic simulation of the maximum extractable Gibbs energy, was first performed. After which, a series of bench-scale experiments were conducted to obtain realistic extractable energy data. The results showed that concentrated fertilisers potentially have 11 times higher energy than seawater. Even after accounting for the irreversibility losses due to constant pressure operation, the investigated pure fertilisers were found to have between 2.5 and 4.6 Wh/kg of energy. The outcomes from the flux and power density modelling were then validated with real experimental data. This study has successfully demonstrated that concentrated fertilisers can release a substantial amount of chemical potential energy when diluted for fertigation. This energy could be harnessed by transforming it into electric energy or pressure energy via PRO

Deep Neural Networks - A Brief History

Introduction to deep neural networks and their history.Comment: 14 pages, 14 figure

Long-range ballistic propagation of carriers in methylammonium lead iodide perovskite thin films

© 2019, The Author(s), under exclusive licence to Springer Nature Limited. The performance of semiconductor devices is fundamentally governed by charge-carrier dynamics within the active materials1–6. Although advances have been made towards understanding these dynamics under steady-state conditions, the importance of non-equilibrium phenomena and their effect on device performances remains elusive7,8. In fact, the ballistic propagation of carriers is generally considered to not contribute to the mechanism of photovoltaics (PVs) and light-emitting diodes, as scattering rapidly disrupts such processes after carrier generation via photon absorption or electric injection9. Here we characterize the spatiotemporal dynamics of carriers immediately after photon absorption in methylammonium lead iodide perovskite films using femtosecond transient absorption microscopy (fs-TAM) with a 10 fs temporal resolution and 10 nm spatial precision. We found that non-equilibrium carriers propagate ballistically over 150 nm within 20 fs of photon absorption. Our results suggest that in a typical perovskite PV device operating under standard conditions, a large fraction of carriers can reach the charge collection layers ballistically. The ballistic transport distance appears to be limited by energetic disorder within the materials, probably due to disorder-induced scattering. This provides a direct route towards optimization of the ballistic transport distance via improvements in materials and by minimizing the energetic disorder. Our observations reveal an unexplored regime of carrier transport in perovskites, which could have important consequences for device performance

Health-related Quality of Life in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Multi-center UK Study

BACKGROUND & AIMS: It is unclear whether health-related quality of life (HRQoL) is impaired in patients with nonalcoholic fatty liver disease (NAFLD) without advanced fibrosis and how this compares with the general population. We aimed to assess HRQoL in patients with NAFLD in comparison to the general population and any associations of fibrosis severity and metabolic comorbidities with impairments in HRQoL. METHODS: We prospectively enrolled 513 consecutive patients with NAFLD who completed the EuroQol 5-dimensional questionnaire (EQ-5D) and Chronic Liver Disease Questionnaires (CLDQ). Demographic and clinical information, liver biopsy results, and/or liver stiffness (LS) by transient elastography were recorded. A general population sub-cohort of the Health Survey for England 2018 was used as a comparator (n = 5483), and a 1:1 propensity-score (PS) matching was performed, according to age, sex, body mass index, and type 2 diabetes mellitus (T2DM). RESULTS: EQ-5D-5L utility was significantly lower in 466 PS-matched patients with NAFLD compared with PS-matched controls (0.77 ± 0.27 vs 0.84 ± 0.19; P < .001), even in those without advanced fibrosis (F ≤2 or LS <8kPa) (0.80 ± 0.24 vs 0.84 ± 0.19; P = .024). HRQoL measures (EQ-5D-5L, EQ-VAS, CLDQ) did not differ between patients with NAFLD with and without advanced fibrosis. LS was independently associated with lower EQ-5D-5L in all patients with NAFLD but not in those without advanced fibrosis. In the latter, lower EQ-5D-5L was associated with female sex, T2DM, and depression. CONCLUSIONS: Patients with NAFLD, even those without advanced fibrosis, have worse HRQoL compared with the general population. In patients with NAFLD without advanced fibrosis, HRQoL is independently associated with non-liver comorbidities but not LS. Multi-disciplinary management is therefore required in NAFLD, irrespective of fibrosis severity

Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza

Background: The value of neuraminidase inhibitors (NAIs) in reducing severe clinical outcomes from influenza is debated. A clinical trial to generate better evidence is desirable. However, it is unknown whether UK clinicians would support a placebo controlled trial. A survey was conducted to determine the attitude of clinicians towards a clinical trial and their current practice in managing adults admitted to hospital with suspected influenza. Methods: Senior clinicians (n=50) across the UK actively involved in the care of patients hospitalised with severe respiratory infections and/or respiratory infection research were invited to participate in an on-line survey. Participants were asked their opinion on the evidence for benefit of NAIs in influenza, their current practice in relation to: a) testing for influenza; b) treating empirically with NAIs; and c) when influenza infection is virolologically confirmed, prescribing NAIs. Results: Thirty-five (70%) of 50 clinicians completed the survey. Respondents were drawn mainly from infectious diseases, intensive care and respiratory medicine. Only 11 (31%) of 35 respondents agreed that NAIs are effective at reducing influenza mortality;14(40%)disagreed, 10 (28.6%) neither agreed nor disagreed. When managing adults admitted to non-ICU wards with a respiratory infection during an influenza season, 15 (51.7%) clinicians indicated they would usually perform a test for influenza in greater than 60% of patients but only 9 (31%) would treat empirically with NAIs in greater than 60% of patients. Few clinicians would either test or empirically treat patients presenting with other (non-respiratory infection related) diagnoses. If influenza infection is confirmed, 17 (64.5%) clinicians would prescribe NAIs in greater than 80% of patients with a respiratory infection treated on non-ICU wards Thirty-one (89%) clinicians agreed that a placebo-controlled clinical trial should be conducted and 29 (85%) would participate in such a trial. Conclusions: There is strong support from UK clinicians for a placebo-controlled trial of NAI treatment in adults hospitalised with suspected influenza. Current variation in medical opinion and clinical practice demonstrates collective equipoise, supporting ethical justification for a trial. Low use of NAIs in the UK suggests randomisation of treatment would not substantially divert patients towards placebo